New pulmonary therapies directed at targets other than CFTR.
about
Inhibition of ENaC by endothelin-1Early pulmonary inflammation and lung damage in children with cystic fibrosisMechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blockerInhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis.Role of CFTR in epithelial physiology.Epithelial Sodium Channel ENaC is a Modifier of the Long Term Non-progressive Phenotype Associated with F508del CFTR Mutations.The Epithelial Sodium Channel (αENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors.
P2860
Q27005957-AADBE465-92BF-4541-A323-CAC664C323EFQ27027040-BBA3059F-AE4E-4C03-A57D-CFCAF015BE46Q28601949-5913F4E7-5B33-41A3-9ED6-F7F0BBD7E03BQ36913746-2BED4618-AA1B-4144-8D3F-E799FF57F539Q37553595-B33487CA-1BE9-429C-B432-C6395CB808B5Q38679109-E3CAA044-D5D1-47AA-9547-6FF0C2BB9D9AQ50137398-EEE588B6-AEE3-464B-AB7C-C778DBDF4D34
P2860
New pulmonary therapies directed at targets other than CFTR.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New pulmonary therapies directed at targets other than CFTR.
@en
type
label
New pulmonary therapies directed at targets other than CFTR.
@en
prefLabel
New pulmonary therapies directed at targets other than CFTR.
@en
P2860
P1476
New pulmonary therapies directed at targets other than CFTR
@en
P2093
Scott H Donaldson
P2860
P356
10.1101/CSHPERSPECT.A009787
P577
2013-06-01T00:00:00Z